Study IDs gene that raises risk of ONJ
Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing osteonecrosis of the jaw (ONJ) in patients who take bisphosphonates (Oncologist, January 20, 2012). The discovery paves the way for a genetic screening test to determine who can safely take these drugs, according to the researchers. Oral bisphosphonates are currently taken by some 3 million women in the U.S. for

